Pfizer to set up new hub at Swansea University in Wales

Giant Pfizer is planning to collaborate on a new Innovation Hub at Swansea University’s new £450 million Bay Campus.and also work with Institute of Life Science (ILS) academics at the Singleton Campus medical school. The company joins forces with Swansea University in a bid to improve healthcare in the region.

The new partnership has been announced by the company’s UK managing director Eric Nordkamp at a conference underlining also how much essential and crucial is the cooperation between the pharmaceutical sector, academia and the NHS to tackle today’s health demands: “Through sharing our different skills and expertise we really can make a difference to improving health outcomes for patients, developing new ways of supporting the provision of healthcare.”

Professor Richard Davies, vice-chancellor of Swansea University , welcomed the partnership, and added: “This exciting new collaboration with Pfizer, one of the world’s largest research-based biopharmaceutical companies, is part of an intensified mission of mobilising the university’s resources in support of the NHS Wales, working closely with health boards.”